Who is ... Professor Dr. Brunhilde Wirth?

Brunhilde Wirth earned her degree in Biology in 1982 and a specialization in Applied Genetics in 1983 at the University of Bucharest. She began her research career in Bonn in 1986 and earned her doctoral degree in Natural Sciences (Dr. rer. nat.) in 1989.
Her postdoctoral journey took her to the renowned Imperial Cancer Research Fund Laboratories in London, funded by the German Research Foundation (DFG) - a formative period that deepened her expertise in molecular genetics.

Returning to Bonn in 1990, she took on leadership roles and completed her habilitation in Human Genetics in 1996. In 1999, she was appointed to the C4 Professorship in Human Genetics at the University of Cologne. Tasked with establishing a new institute, she successfully built the Institute of Human Genetics from the ground up, which officially opened its doors in 2004 with a dedicated team of researchers and clinicians.

At the helm of the Neuromuscular and Skeletal Disorders research group, Prof. Wirth has dedicated decades to uncovering the genetic and molecular mechanisms underlying SMA, osteoporosis, and bone development. Her laboratory employs cutting-edge tools such as genome and exome sequencing, transcriptome profiling, genome editing, induced pluripotent stem cell (iPSC) models, and advanced biochemical and cellular assays.

Prof. Wirth made a landmark discovery that certain individuals genetically predisposed to SMA remain symptom-free thanks to protective “modifier” genes such as PLS3 and NCALD. These findings not only advanced our biological understanding of SMA but also opened new therapeutic pathways, leading to patents and translational research initiatives.
Prof Wirth and her team have identified the disease-causing gene and elucidated the pathomechanism for thirteen  neuromuscular disorders. Among these, her group also contributed to identifying VAMP1 mutations as the cause of a novel congenital myasthenic syndrome, expanding the genetic spectrum of neuromuscular diseases.

Her pioneering contributions have been honored with numerous awards, including:

• Sanofi-Wintrop Myopathy Prize (1996)
• Motor Neuron Diseases Science Award (2001)
• NRW Innovation Award (2019)
• Duchenne-Erb Prize (2023) for lifetime achievement in SMA research

Prof. Wirth is deeply engaged in the broader scientific ecosystem. She has served as chair of the ESHG and the SMA Europe scientific program committee, and has been a member and chair of the jury of the Max Delbrück Zukunftspreis. She also participates in the Center for Molecular Medicine Cologne's (CMMC) review boards and contributes to program committees for international conferences and leading genetics societies.

With over 250 peer-reviewed publications, an h-index of ~73, and more than 23,300 citations, Prof. Wirth ranks among the most influential scientists in neurogenetics and human genetics. Her work is widely cited, and her research findings have shaped both academic understanding and clinical practice in neuromuscular disorders.

PubMed Link